SHL TeleMedicine Ltd.
(NASDAQ: SHLT)
|
8:30 PM UTC, 07/02/24 | |||
---|---|---|---|---|
Last: $5.09 | Change: -0.01 | %Change: -0.13% | Volume: 355 |
Open: | $ 5.09 | Volume: | 355 | |
---|---|---|---|---|
High: | $ 5.09 | Yield(%) | 0.00 | |
Low: | $ 5.09 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 83.43M | |
EPS ($) | 0.08 | Shares Out: | 16.39M |
% Price Change (last 4 weeks): | -2.68 |
---|---|
% Price Change (last 13 weeks): | -19.21 |
% Price Change (last 26 weeks): | -38.67 |
% Price Change (last 52 weeks): | -51.25 |
% Price Change (year to date): | -36.18 |
Return on Equity (%): | -10.89 |
---|---|
Return on Assets (%): | -6.29 |
Return on Invested Capital (%): | -3.07 |
Gross Profit Margin (%): | 34.25 |
---|---|
Net Profit Margin (%): | -12.36 |
Operating Profit Margin (%): | -11.93 |
50-day Moving Average: | $3.24 |
---|---|
200-day Moving Average: | $6.02 |
Avg. Daily Vol. (last 50 days): | 1,907 |
Avg. Daily Vol. (last 200 days): | 3,184 |
52-wk high: | $12.00 |
52-wk low: | $4.06 |
Bid: | $2.11 |
Ask: | $5.33 |
SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Its products and solutions include congestive heart failure, chronic obstructive pulmonary disease and cardiac monitoring services. It operates through the following geographical segments: Israel, Europe principally Germany, and Rest of the World. The company was founded by Yoram Alroy and Elon Shalev in 1987 and is headquartered in Tel Aviv, Israel.
|
SHL TeleMedicine Ltd.
Ashdar Building 90 Yigal Alon Street Tel Aviv TA 67891 Phone: 972.3.561.2212 Fax: 972.3.624.2414 http://www.shl-telemedicine.com |
Earnings (1year) ($): | -0.43 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 4.49 |
Cash Flow ($): | 0.04 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 2.28 |
Price/Book (x): | 1.78 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 2.08 |
---|---|
Current Ratio (x): | 2.30 |
LT Debt/Equity (x): | 20.72 |
Total Debt/Equity (x): | 27.00 |